A. Tami, B. van der Gun, K. Wold, M. Vincenti-González, A. Veloo, et al.
Contributing partner:
University Medical Center Groningen (UMCG)
Scientific article available at:
“PLOS ONE”
Author: aleksandr.belonozhkin
Clinical role of monoclonal antibodies in the treatment of high-risk patients with SARS-CoV-2 breakthrough infections: a prospective cohort study
A. Savoldi, M. Morra, A. Castelli, M. Mirandola, M. Berkell et al.
Contributing partner:
University of Bologna (UNIBO)
Helmholtz Zentrum München (HMGU)
University of Antwerp (UAntwerp)
Scientific article available at:
“MDPI Open Access Journals”
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers
S. Porru, M. G. L. Monaco, G. Spiteri, A. Carta, M. D. Pezzani et al.
Contributing partner:
University of Bologna (UNIBO)
University of Verona (UNIVR)
Scientific article available at:
“MDPI Open Access Journals”
Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children
C. D. Chiara, S. Carraro, S. Zanconato, S. Cozzani, E. Baraldi et al.
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“National Library of Medicine”
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response
E. Tacconelli, A. Gorska, E. Carrara, R. J. Davis, M. Bonten et al.
Contributing partner:
University of Verona (UNIVR)
University Medical Center Groningen (UMCG)
Scientific article available at:
“The Lancet Regional Health – Europe”
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern
F. Mazzaferri, M. Mirandola, A. Savoldi, P. D. Nardo, M. Morra et al.
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
eLife (elifesciences.org)
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
A. L. Batchi-Bouyou, J. C. Djontu, J. C. Vouvoungui, C. C. M. Mapanguy, L. L. Ingoba et al.
Contributing partner:
The Congolese Foundation for Medical Research (FCRM)
Scientific article available at:
“BMC Infectious Diseases”
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV
J.Warszawski, L. Meyer, J.-E. Franck, D. Rahib, N. Lydié et al.
Contributing partner:
French National Institute of Health and Medical Research (INSERM)
Scientific article available at:
“PLOS ONE”
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
S. Zanelli, E. Fiorio, I. Zampiva, D. Gibellini, G. Verlato et al.
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Annals of Oncology”
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study
A.Savoldi, M.Morra, P. D. Nardo, A. M. Cattelan, M. Mirandola et al.
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“European Journal of Clinical Microbiology & Infectious Diseases”